{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:22:52Z","timestamp":1740126172059,"version":"3.37.3"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,23]]},"abstract":"<jats:p>Morgellons disease (MD) greatly affects a patient\u2019s quality of life (QoL). Therefore, we aimed to measure the disease burden of MD on QoL and compare it with well-funded dermatological conditions, including prurigo nodularis (PN), atopic dermatitis (AD) and psoriasis. This qualitative cross-sectional survey, comprising Dermatology Life Quality Index (DLQI), Pittsburgh Sleep Quality Index (PSQI) and 5-D itch scale questionnaires, was distributed to patients with untreated MD seen at the Oregon Health and Science University Dermatology clinic from July 2022 to July 2023. When comparing mean scores across dermatological conditions, MD had significantly higher DLQI scores than PN, AD and psoriasis, and significantly higher PSQI scores than AD and psoriasis.<\/jats:p>","DOI":"10.1093\/bjd\/ljae335","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T08:48:27Z","timestamp":1724143707000},"page":"163-165","source":"Crossref","is-referenced-by-count":0,"title":["Patients with Morgellons disease have a lower quality of life than patients with psoriasis, atopic dermatitis and prurigo nodularis"],"prefix":"10.1093","volume":"192","author":[{"given":"Mackenzie O","family":"Gipple","sequence":"first","affiliation":[{"name":"Oregon Health and Science University School of Medicine , Portland, OR ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2409-4067","authenticated-orcid":false,"given":"Ramneek K","family":"Dhami","sequence":"additional","affiliation":[{"name":"University of Nevada, Reno School of Medicine , Reno, NV ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emile","family":"Latour","sequence":"additional","affiliation":[{"name":"Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health and Science University , Portland, OR ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse J","family":"Keller","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Oregon Health and Science University , Portland, OR ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"2024122223514379300_ljae335-B1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/CCID.S152343","article-title":"History of Morgellons disease: from delusion to definition","volume":"11","author":"Middelveen","year":"2018","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2024122223514379300_ljae335-B2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jaad.2011.12.012","article-title":"Delusional infestation: clinical presentation in 147 patients seen at Mayo Clinic","volume":"67","author":"Foster","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"2024122223514379300_ljae335-B3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5070\/D328559260","article-title":"Dermatology urgent care model reduces costs and healthcare utilization for psychodermatology patients \u2013 a retrospective chart review","volume":"28","author":"Johnson","year":"2022","journal-title":"Dermatol Online J"},{"key":"2024122223514379300_ljae335-B4","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/ced.14722","article-title":"Clinical characteristics and disease burden in prurigo nodularis","volume":"46","author":"Aggarwal","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"2024122223514379300_ljae335-B5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00403-023-02768-2","article-title":"Skin biopsies of patients with Morgellons disease show increased oncostatin M expression relative to healthy controls","volume":"316","author":"Keller","year":"2024","journal-title":"Arch Dermatol Res"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljae335\/59203445\/ljae335.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/192\/1\/163\/59203445\/ljae335.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/192\/1\/163\/59203445\/ljae335.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T23:51:49Z","timestamp":1734911509000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/192\/1\/163\/7738006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":5,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,8,21]]},"published-print":{"date-parts":[[2024,12,23]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljae335","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"type":"print","value":"0007-0963"},{"type":"electronic","value":"1365-2133"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,8,21]]}}}